Live Animals Market Key Trends, Size, Outlook, Overview 2024-2033

Overview and Scope

Live animals refer to all living organisms (other than humans) including birds, fish, crustacean, insects, reptiles, worms and developing eggs as well. They are divided into subcategories based on the types of animals they are. These are intended for breeding, production of milk, meat and eggs or labor.

Sizing and Forecast

The live animals market size has grown strongly in recent years. It will grow from $2653.24 billion in 2023 to $2838.3 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to agricultural practices and livestock farming, food consumption patterns, livestock trade and exports, cultural and religious practices, pet industry growth..

The live animals market size is expected to see strong growth in the next few years. It will grow to $3633.81 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to global population growth, changing dietary preferences, animal welfare and ethical considerations, companion animal trends, emerging markets and urbanization.. Major trends in the forecast period include animal welfare concerns, technology integration, sustainability and environmental impact, pandemic effects, genetic innovations, .

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/live-animals-global-market-report

Segmentation & Regional Insights

The live animals market covered in this report is segmented –

1) By Animal Type: Cattle and Buffalo, Pig, Poultry, Sheep and Goat, Other Animals

2) By Distribution Channel: Business To Consumers (B2C), Business To Business (B2B)

Asia-Pacific was the largest region in the live animals market in 2023. The regions covered in the live animals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9678&type=smp

Major Driver Impacting Market Growth

Increasing meat consumption is expected to propel the live animal market going forward. Meat refers to animal flesh that is consumed as food and can be a component of a balanced diet. They supply B vitamins, iron, and high-quality protein. Live animals are used for producing meat and consumed as food, so increasing meat consumption will propel market growth. For instance, in July 2021, according to the Food and Agriculture Organization (FAO) agriculture report outlook 2021–2030 shared by the Organization for Economic Co-operation and Development (OECD), a France-based intergovernmental organization to defeat hunger and improve nutrition and food security, the global meat consumption per capita is expected to increase by 0.3% p.a. to 35.4 kg in retail weight equivalent by 2030, and further global consumption of meat proteins is expected to increase by 14% by 2030. Therefore, increasing meat consumption is driving the growth of the live animal market.

Key Industry Players

Major companies operating in the live animals market are focused on introducing innovative treatment solutions, such as monoclonal antibodies, for live animal deadly diseases, such as canine parvovirus, to gain a competitive edge in the market. Monoclonal antibodies represent a large class of therapeutic biological products that continue to transform modern medicine. They are used in a wide range of clinical indications, including areas such as hematology, immunology, oncology, and infectious diseases. For instance, in May 2023, Elanco Animal Health Inc., a US-based pharmaceutical company, launched the Canine Parvovirus Monoclonal Antibody, the first and only treatment for devastating dog disease. The treatment can be administered to dogs eight weeks of age or older with canine parvovirus. With a single dose efficaciousness and a solid safety profile in healthy dogs, the canine parvovirus monoclonal antibody therapy targets the virus and may offer a less intense and more effective option than supportive care alone.

The live animals market report table of contents includes: